Viva Biotech Holdings (VB0) — Financial Flexibility Index
Viva Biotech Holdings (VB0) has a Financial Flexibility Index of 0.05x as of June 2023. Free cash flow of €209.53 Million (operating CF €158.72 Million minus capex €50.80 Million) represents 0% of total liabilities (€4.51 Billion). Check Viva Biotech Holdings strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Viva Biotech Holdings Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Viva Biotech Holdings across 9 annual periods. See how liquid is Viva Biotech Holdings's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Viva Biotech Holdings (2016–2024)
Year-by-year free cash flow to debt coverage for Viva Biotech Holdings. For the full company profile including market capitalisation, see market value of Viva Biotech Holdings.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.17x | €565.66 Million | €373.99 Million | €3.23 Billion | ▲ +15.2% |
| 2023 | 0.15x | €571.24 Million | €383.40 Million | €3.76 Billion | ▲ +3.1% |
| 2022 | 0.15x | €635.38 Million | €386.05 Million | €4.32 Billion | ▼ -5.4% |
| 2021 | 0.16x | €643.01 Million | €77.83 Million | €4.13 Billion | ▲ +7.6% |
| 2020 | 0.14x | €635.80 Million | €43.18 Million | €4.40 Billion | ▼ -82.8% |
| 2019 | 0.84x | €102.20 Million | €46.01 Million | €121.39 Million | ▲ +296.5% |
| 2018 | 0.21x | €59.01 Million | €12.11 Million | €277.90 Million | ▼ -77.5% |
| 2017 | 0.94x | €46.81 Million | €27.89 Million | €49.64 Million | ▼ -16.1% |
| 2016 | 1.12x | €28.46 Million | €21.12 Million | €25.32 Million | — |